Filamin A-mediated down-regulation of the exchange factor Ras-GRF1 correlates with decreased matrix metalloproteinase-9 expression in human melanoma cells

被引:49
作者
Zhu, Tie-Nian
He, Hua-Jun
Kole, Sutapa
D'Souza, Theresa
Agarwal, Rachana
Morin, Patrice J.
Bernier, Michel
机构
[1] NIA, Diabet Sect, NIH, Clin Invest Lab, Baltimore, MD 21224 USA
[2] NIA, Cellular & Mol Biol Lab, NIH, Baltimore, MD 21224 USA
关键词
D O I
10.1074/jbc.M611430200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The actin-binding protein filamin A (FLNa) is associated with diverse cellular processes such as cell motility and signaling through its scaffolding properties. Here we examine the effect of FLNa on the regulation of signaling pathways that control the expression of matrix metalloproteinases (MMPs). The lack of FLNa in human M2 melanoma cells was associated with constitutive and phorbol ester-induced expression and secretion of active MMP-9 in the absence of MMP-2 up-regulation. M2 cells displayed stronger MMP-9 production and activity than their M2A7 counterparts where FLNa had been stably reintroduced. Using an MMP-9 promoter construct (pMMP-9-Luc), in vitro kinase assays, and genetic and pharmacological approaches, we demonstrate that FLNa mediated transcriptional down-regulation of pMMP-9-Luc by suppressing the constitutive hyperactivity of the Ras/MAPK extracellular signal-regulated kinase (ERK) cascade. Experimental evidence indicated that this phenomenon was associated with destabilization and ubiquitylation of Ras-GRF1, a guanine nucleotide exchange factor that activates H-Ras by facilitating the release of GDP. Ectopic expression of Ras-GRF1 was accompanied by ERK activation and elevated levels of MMP-9 in M2A7 cells, whereas a catalytically inactive dominant negative Ras-GRF1, which prevented ERK activation, reduced MMP-9 expression in M2 cells. Our results indicate that expression of FLNa regulates constitutive activation of the Ras/ERK pathway partly through a Ras-GRF1 mechanism to modulate the production of MMP-9.
引用
收藏
页码:14816 / 14826
页数:11
相关论文
共 72 条
[1]  
Anborgh PH, 1999, MOL CELL BIOL, V19, P4611
[2]  
Anilkumar G, 2003, CANCER RES, V63, P2645
[3]   Activation of H-Ras in the endoplasmic reticulum by the RasGRF family guanine nucleotide exchange factors [J].
Arozarena, I ;
Matallanas, D ;
Berciano, MT ;
Sanz-Moreno, V ;
Calvo, F ;
Muñoz, MT ;
Egea, G ;
Lafarga, M ;
Crespo, P .
MOLECULAR AND CELLULAR BIOLOGY, 2004, 24 (04) :1516-1530
[4]   The Rho family GTPase Cdc42 regulates the activation of Ras/MAP kinase by the exchange factor Ras-GRF [J].
Arozarena, I ;
Aaronson, DS ;
Matallanas, D ;
Sanz, V ;
Ajenjo, N ;
Tenbaum, SP ;
Teramoto, H ;
Ighishi, T ;
Zabala, JC ;
Gutkind, JS ;
Crespo, P .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (34) :26441-26448
[5]   The N-terminal moiety of CDC25(Mm), a GDP/GTP exchange factor of Ras proteins, controls the activity of the catalytic domain - Modulation by calmodulin and calpain [J].
Baouz, S ;
Jacquet, E ;
Bernardi, A ;
Parmeggiani, A .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (10) :6671-6676
[6]   Activation of Vav/Rho GTPase signaling by CXCL12 controls membrane-type matrix metalloproteinase-dependent melanoma cell invasion [J].
Bartolomé, RA ;
Molina-Ortiz, I ;
Samaniego, R ;
Sánchez-Mateos, P ;
Bustelo, XR ;
Teixidó, J .
CANCER RESEARCH, 2006, 66 (01) :248-258
[7]   The Rac1-and RhoG-specific GEF domain of Trio targets filamin to remodel cytoskeletal actin [J].
Bellanger, JM ;
Astier, C ;
Sardet, C ;
Ohta, Y ;
Stossel, TP ;
Debant, A .
NATURE CELL BIOLOGY, 2000, 2 (12) :888-892
[8]   REGULATED AND CONSTITUTIVE ACTIVITY BY CDC25(MM) (GRF), A RAS-SPECIFIC EXCHANGE FACTOR [J].
CEN, H ;
PAPAGEORGE, AG ;
VASS, WC ;
ZHANG, K ;
LOWY, DR .
MOLECULAR AND CELLULAR BIOLOGY, 1993, 13 (12) :7718-7724
[9]   A synaptic Ras-GTPase activating protein (p135 SynGAP) inhibited by CaM kinase II [J].
Chen, HJ ;
Rojas-Soto, M ;
Oguni, A ;
Kennedy, MB .
NEURON, 1998, 20 (05) :895-904
[10]   Close encounters of many kinds: Fos-Jun interactions that mediate transcription regulatory specificity [J].
Chinenov, Y ;
Kerppola, TK .
ONCOGENE, 2001, 20 (19) :2438-2452